Yokukansan improves behavioral and psychological symptoms of dementia by suppressing dopaminergic function.

about

Yokukansan improves behavioral and psychological symptoms of dementia by suppressing dopaminergic function.

Item

http://www.wikidata.org/entity/Q36710267

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Yokukansan improves behavioral ...... ressing dopaminergic function.

@ast

Yokukansan improves behavioral ...... ressing dopaminergic function.

@en

type

Item

label

Yokukansan improves behavioral ...... ressing dopaminergic function.

@ast

Yokukansan improves behavioral ...... ressing dopaminergic function.

@en

prefLabel

Yokukansan improves behavioral ...... ressing dopaminergic function.

@ast

Yokukansan improves behavioral ...... ressing dopaminergic function.

@en

P1476

Yokukansan improves behavioral ...... ressing dopaminergic function.

@en

P2093

Kenji Takeyoshi

http://www.w3.org/2001/XMLSchema#string

Masatake Kurita

http://www.w3.org/2001/XMLSchema#string

Mika Teranishi

http://www.w3.org/2001/XMLSchema#string

Satoshi Nishino

http://www.w3.org/2001/XMLSchema#string

Tadahiro Sato

http://www.w3.org/2001/XMLSchema#string

Yoshiro Okubo

http://www.w3.org/2001/XMLSchema#string

Yukio Numata

http://www.w3.org/2001/XMLSchema#string

P2860

“Mini-mental state”

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

Efficacy and adverse effects of atypical antipsychotics for dementia: meta-analysis of randomized, placebo-controlled trials.

The noradrenaline metabolite MHPG is a candidate biomarker from the manic to the remission state in bipolar disorder I: a clinical naturalistic study

Comparison of citalopram, perphenazine, and placebo for the acute treatment of psychosis and behavioral disturbances in hospitalized, demented patients.

Pharmacotherapy of behavioral and psychological symptoms of dementia: time for a different paradigm?

Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs.

A randomized, observer-blind, controlled trial of the traditional Chinese medicine Yi-Gan San for improvement of behavioral and psychological symptoms and activities of daily living in dementia patients.

A randomized cross-over study of a traditional Japanese medicine (kampo), yokukansan, in the treatment of the behavioural and psychological symptoms of dementia.

Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials.

P304

641-649

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/NDT.S99032

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-03-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27042075

http://www.w3.org/2001/XMLSchema#string

P921

dopamine

P932

4801203

http://www.w3.org/2001/XMLSchema#string